Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mannose Receptor C-type 1 (MRC1), also known as CD206, is a type I transmembrane protein belonging to the C-type lectin family. It functions as an endocytic and phagocytic receptor, recognizing high-mannose glycans on pathogens and endogenous proteins. MRC1 plays a crucial role in innate immunity, immune modulation, and antigen presentation. Dysregulation of MRC1 is implicated in infectious diseases, inflammatory disorders, and cancer, making it a potential therapeutic target and biomarker.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mannose Receptor C-type 1 (MRC1).